Optomed Oyj

Helsinki Stock Exchange OPTOMED.HE

Optomed Oyj Free Cash Flow Per Share for the year ending December 31, 2023: USD -0.20

Optomed Oyj Free Cash Flow Per Share is USD -0.20 for the year ending December 31, 2023, a 49.31% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.
  • Optomed Oyj Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.39, a 15.51% change year over year.
  • Optomed Oyj Free Cash Flow Per Share for the year ending December 31, 2021 was USD -0.47, a -9.69% change year over year.
  • Optomed Oyj Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.43, a -166.07% change year over year.
  • Optomed Oyj Free Cash Flow Per Share for the year ending December 31, 2019 was USD -0.16, a -3.90% change year over year.
Key data
Date Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE) Return on Capital Employed (ROCE)
Market news
Loading...
SV Wall Street
Helsinki Stock Exchange: OPTOMED.HE

Optomed Oyj

Description

Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. The company develops, manufactures, and sells fundus camera products, which are used by ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals. It offers camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Polaris, and Optomed Halo brands, as well as OEM cameras, including Pictor Plus, Pictor Prestige, Visuscout 100, Fundus Module 300, and Signal brand names. The company also provides Avenue Eye Screen, a workflow management software for screening and monitoring of eye diseases, such as diabetic retinopathy; Avenue Archive, an application software for displaying, archiving, and transmitting healthcare information; Avenue Telemedicine, a telemedicine solution for remote image analysis; Avenue AI, an automated diabetic retinopathy screening service; and Avenue Sync, a software solution for integrating fundus camera to the hospital image archive and worklist server. In addition, it offers Avenue Cancer Screen, a screening process management software for breast, cervical, and colorectal cancer; Optomed RIS, a software solution for healthcare imaging units for enhancing the diagnostic process and treatment decisions; Sectra PACS, a modular system optimized for use by high production healthcare providers; Optomed Service Portal, a support function for healthcare units that order and produce imaging services; Facad, a tracing software for visible light imaging and cephalometric measurements; and Sectra PACS Pathology, a digital pathology solution, which allows scanned glass slides to be distributed and diagnosed. Further, the company provides professional IT consulting services for government institutions. It sells its products and solutions through OEMs, distributors, and direct sales. The company's customers include hospitals, eye clinics, and optician chains and stores. The company was incorporated in 2004 and is headquartered in Oulu, Finland.

Similar companies

HARVIA.HE

Harvia Oyj

USD 48.17

-1.24%

KAMUX.HE

Kamux Oyj

USD 2.85

-1.19%

TEM1V.HE

Tecnotree Oyj

USD 4.31

-2.80%

REG1V.HE

Revenio Group Oyj

USD 31.42

-0.08%

QTCOM.HE

Qt Group Oyj

USD 83.23

1.45%

StockViz Staff

February 6, 2025

Any question? Send us an email